Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Skin is the largest organ of the body and serves as the principle barrier to the environment. Composed of multiple cell types arranged in stratified layers with highly specialized appendages, it serves sensory and immune surveillance roles in addition to its primary mechanical function. Several complex in vitro models of skin (i.e. microphysiological systems (MPS) including but not limited to 3D tissues, organ-on-a-chip, organoids), have been developed and assays validated for regulatory purposes. As such, skin is arguably the most advanced organ with respect to model development and adoption across industries including chemical, cosmetic, and to a somewhat lesser extent, pharmaceutical. Early adoption of complex skin models and associated assays for assessment of irritation and corrosion spurred research into other areas such as sensitization, absorption, phototoxicity, and genotoxicity. Despite such considerable advancements, opportunities remain for immune capabilities, inclusion of appendages such as hair follicles, fluidics, and innervation, among others. Herein, we provide an overview of current complex skin model capabilities and limitations within the drug development scheme, and recommendations for future model development and assay qualification and/or validation with the intent to facilitate wider adoption of use within the pharmaceutical industry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These consortia not only promote MPS and OoC adoption but also generate lists of reference compounds relevant to various organ systems (Ainslie et al., 2019; Baudy et al., 2020; Hardwick et al., 2020; Peters et al., 2020; Phillips et al., 2020; Pointon et al., 2021).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Hardwick et al., 2020
Citations
Cites
Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
Ståhl, P. L., Salmén, F., Vickovic, S., Lundmark, A., Navarro, J. F., Magnusson, J., Giacomello, S., Asp, M., Westholm, J. O., Huss, M., et al. (2016) · Science · doi:10.1126/science.aaf2403 · Cited by 3,834
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127
Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones
JANCSÓ, G., KIRALY, E., & JANCSÓ-GÁBOR, A. (1977) · Nature · doi:10.1038/270741a0 · Cited by 1,282
Cytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Casarett and Doull's Toxicology: The Basic Science of Poisons
TIMBRELL, J. A. (1981) · Biochemical Society Transactions · doi:10.1042/bst0090255a · Cited by 875
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Illing, P. T., Vivian, J. P., Dudek, N. L., Kostenko, L., Chen, Z., Bharadwaj, M., Miles, J. J., Kjer-Nielsen, L., Gras, S., Williamson, N. A., et al. (2012) · Nature · doi:10.1038/nature11147 · Cited by 696
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Globally Harmonized System of Classification and Labelling of Chemicals (GHS)
(2016) · Globally harmonized system of classification and labelling of chemicals · doi:10.18356/a6a925c3-en · Cited by 511
Cottrez, F., Boitel, E., Ourlin, J.-C., Peiffer, J.-L., Fabre, I., Henaoui, I.-S., Mari, B., Vallauri, A., Paquet, A., Barbry, P., et al. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.01.007 · Cited by 499
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. M. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.3.207 · Cited by 393
Chen, A. P., Setser, A., Anadkat, M. J., Cotliar, J., Olsen, E. A., Garden, B. C., & Lacouture, M. E. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.02.010 · Cited by 350
Dermal Absorption and Toxicity Assessment
(2007) · CRC Press eBooks · doi:10.3109/9780849375927 · Cited by 340
The use of skin models in drug development
Mathes, S. H., Ruffner, H., & Graf-Hausner, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.006 · Cited by 318
Hayes' Principles and Methods of Toxicology
(2014) · CRC Press eBooks · doi:10.1201/b17359 · Cited by 280
Schäfer-Korting, M., Bock, U., Diembeck, W., Düsing, H.-J., Gamer, A., Haltner-Ukomadu, E., Hoffmann, C., Kaca, M., Kamp, H., Kersen, S., et al. (2008) · Alternatives to Laboratory Animals · doi:10.1177/026119290803600207 · Cited by 238
Piroird, C., Ovigne, J.-M., Rousset, F., Martinozzi-Teissier, S., Gomes, C., Cotovio, J., & Alépée, N. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.03.009 · Cited by 238
The local lymph node assay: past, present and future
Kimber, I., Dearman, R. J., Basketter, D. A., Ryan, C. A., & Gerberick, G. F. (2002) · Contact Dermatitis · doi:10.1034/j.1600-0536.2002.470601.x · Cited by 211
Langerhans Cells: Sensing the Environment in Health and Disease
Deckers, J., Hammad, H., & Hoste, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00093 · Cited by 196
Drug-induced photosensitivity: Photoallergic and phototoxic reactions
Monteiro, A. F., Rato, M., & Martins, C. (2016) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2016.05.006 · Cited by 171
Fuchs (2016) · doi:10.1016/bs.ctdb.2015.11.033 · Cited by 152
Mechanical forces in skin disorders
Hsu, C., Lin, H., Harn, H. I., Hughes, M. W., Tang, M., & Yang, C. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.03.004 · Cited by 149
Matrix molecules and skin biology
Nyström, A., & Bruckner-Tuderman, L. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.07.025 · Cited by 144
Reconstructed epidermis versus human and animal skin in skin absorption studies
Schreiber, S., Mahmoud, A., Vuia, A., Rübbelke, M. K., Schmidt, E., Schaller, M., Kanďárová, H., Haberland, A., Schäfer, U. F., Bock, U., et al. (2005) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.04.004 · Cited by 128
Ramirez, T., Mehling, A., Kolle, S. N., Wruck, C. J., Teubner, W., Eltze, T., Aumann, A., Urbisch, D., van Ravenzwaay, B., & Landsiedel, R. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.08.002 · Cited by 125
OECD (2017) · OECD series on testing and assessment · doi:10.1787/9789264274822-en · Cited by 121
van den Broek, L. J., Bergers, L. I. J. C., Reijnders, C. M. A., & Gibbs, S. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9737-1 · Cited by 115
Duval, C., Cohen, C., Chagnoleau, C., Flouret, V., Bourreau, E., & Bernerd, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114182 · Cited by 114
Hu, T., Khambatta, Z. S., Hayden, P. J., Bolmarcich, J., Binder, R. L., Robinson, M. K., Carr, G. J., Tiesman, J. P., Jarrold, B. B., Osborne, R., et al. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.03.013 · Cited by 114
Balagula, Y., Rosen, S. T., & Lacouture, M. E. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.06.051 · Cited by 105
Luu-The, V., Duché, D., Ferraris, C., Meunier, J., Leclaire, J., & Labrie, F. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.05.011 · Cited by 104
Eosinophils Increase Neuron Branching in Human and Murine Skin and In Vitro
Foster, E. L., Simpson, E. L., Fredrikson, L. J., Lee, J. J., Lee, N. A., Fryer, A. D., & Jacoby, D. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022029 · Cited by 102
In vitro models for evaluating safety and efficacy of novel technologies for skin drug delivery
Planz, V., Lehr, C., & Windbergs, M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.002 · Cited by 96
Psoriasis and Atopic Dermatitis
Griffiths, C. E. M., van de Kerkhof, P., & Czarnecka-Operacz, M. M. (2017) · Dermatology and Therapy · doi:10.1007/s13555-016-0167-9 · Cited by 93
Chen, X., He, Z., Zhou, Z., Yang, T., Zhang, X., Yang, Y., Duan, W., & Zhou, S. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12455 · Cited by 86
The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells?
Callard, R. E., & Harper, J. I. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.05.003 · Cited by 83
Engineering Functional Epithelium for Regenerative Medicine and In Vitro Organ Models: A Review
Vrana, N. E., Lavall�e, P., Dokmeci, M. R., Dehghani, F., Ghaemmaghami, A. M., & Khademhosseini, A. (2013) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2012.0603 · Cited by 81
Flamand, N., Marrot, L., Belaïdi, J.-P., Linda, B., Dourille, E., Feltes, M., & Meunier, J. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.02.009 · Cited by 80
Mori, T., Ishida, K., Mukumoto, S., Yamada, Y., Imokawa, G., Kabashima, K., Kobayashi, M., Bito, T., Nakamura, M., Ogasawara, K., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09440.x · Cited by 74
Life-threatening dermatologic adverse events in oncology
Rosen, A. C., Balagula, Y., Raisch, D. W., Garg, V., Nardone, B., Larsen, N., Sorrell, J. L., West, D. P., Anadkat, M. J., & Lacouture, M. E. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000032 · Cited by 73
Chijiwa, C., Takeoka, S., Kamata, M., Tateishi, M., Fukaya, S., Hayashi, K., Fukuyasu, A., Tanaka, T. L., Ishikawa, T., Ohnishi, T., et al. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14245 · Cited by 67
Enhanced Absorption through Damaged Skin: An Overview of the in vitro Human Model
Gattu, S., & Maïbach, H. I. (2010) · Skin Pharmacology and Physiology · doi:10.1159/000288163 · Cited by 66
Alogliptin: a new addition to the class of DPP-4 inhibitors
Rendell, M. (2009) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s4312 · Cited by 64
NCTC 2544 and IL-18 production: A tool for the identification of contact allergens
Corsini, E., Galbiati, V., Mitjans, M., Galli, C. L., & Marinovich, M. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.05.018 · Cited by 63
Direct T-cell stimulations by drugs—bypassing the innate immune system
Pichler, W. J. (2005) · Toxicology · doi:10.1016/j.tox.2004.12.014 · Cited by 63
DPP-4 inhibitors: focus on safety
Tella, S. H., & Rendell, M. S. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.977863 · Cited by 63
Food Sensitivity and the Pathogenesis of Atopic Dermatitis
Sampson, H. A. (1997) · Journal of the Royal Society of Medicine · doi:10.1177/0141076897090030s02 · Cited by 62
Reus, A. A., Reisinger, K., Downs, T. R., Carr, G. J., Zeller, A., Corvi, R., Krul, C. A. M., & Pfuhler, S. (2013) · Mutagenesis · doi:10.1093/mutage/get051 · Cited by 61
Reconstructed skin models as emerging tools for drug absorption studies
Küchler, S., Strüver, K., & Friess, W. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.816284 · Cited by 59
García‐Díez, I., Ivars, M., Aventín, D. L., Ishii, N., Hashimoto, T., Iranzo, P., Pujol, R. M., España, A., & Herrero‐González, J. E. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14005 · Cited by 59
Eskes, C., Cole, T., Hoffmann, S., Worth, A. P., Cockshott, A., Gerner, I., & Zuang, V. (2007) · Alternatives to Laboratory Animals · doi:10.1177/026119290703500608 · Cited by 55
Richter, A., Schmucker, S. S., Esser, P. R., Traska, V., Weber, V., Dietz, L., Thierse, H., Pennino, D., Cavani, A., & Martin, S. F. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.08.007 · Cited by 54
Dahl, E. L., Curren, R., Barnett, B. C., Khambatta, Z. S., Reisinger, K., Ouédraogo, G., Faquet, B., Ginestet, A.-C., Mun, G. C., Hewitt, N. J., et al. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.12.001 · Cited by 47
An in vitro human skin test for assessing sensitization potential
Ahmed, S. S., Wang, X. N., Fielding, M., Kerry, A., Dickinson, I., Munuswamy, R., Kimber, I., & Dickinson, A. M. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3197 · Cited by 47
Casati, S., Aeby, P., Kimber, I., Maxwell, G., Ovigne, J.-M., Roggen, E., Rovida, C., Tosti, L., & Basketter, D. A. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903700313 · Cited by 46
Genomic Allergen Rapid Detection In-House Validation—A Proof of Concept
Johansson, H., Rydnert, F., Kühnl, J., Schepky, A. G., Borrebaeck, C. A. K., & Lindstedt, M. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu046 · Cited by 42
Dermatological Toxicity Associated with Targeted Therapies in Cancer: Optimal Management
Peuvrel, L., & Dréno, B. (2014) · American Journal of Clinical Dermatology · doi:10.1007/s40257-014-0088-2 · Cited by 41
Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice
Lee, J. J., Protheroe, C. A., Luo, H., Ochkur, S. I., Scott, G. D., Zellner, K. R., Raish, R. J., Dahl, M. V., Vega, M. L., Conley, O., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.003 · Cited by 41
Danilenko, D. M., Phillips, G. D. L., & Diaz, D. (2016) · Toxicologic Pathology · doi:10.1177/0192623316632074 · Cited by 40
Alternatives for Dermal Toxicity Testing
Appelgate, L. A., Jafari, P., Scaletta, C., Roessingh, A. D. B., Raffoul, W., & Hirt‐Burri, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-50353-0 · Cited by 39
再構築ヒト皮膚モデル,Episkinによる遺伝毒性試験手順の開発:経皮適用化合物のin vitroでの危険性評価のための新しいツールか?
Flamand, N., Marrot, L., Belaïdi, J.-P., Linda, B., Dourille, E., Feltes, M., & Meunier, J. R. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · Cited by 36
Chemical-induced contact allergy: from mechanistic understanding to risk prevention
Corsini, E., Engin, A. B., Neagu, M. T., Galbiati, V., Nikitovic, D., Tzanakakis, G. N., & Tsatsakis, A. M. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2283-z · Cited by 32
Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors
Cubero, D. D. I. G., Abdalla, B. M. Z., Schoueri, J., Lopes, F. I., Turke, K. C., Guzman, J., del Giglio, A., Filho, C. D. S. M., Salzano, V., & Fabra, D. G. (2018) · Drugs in Context · doi:10.7573/dic.212516 · Cited by 31
Topical absorption and systemic toxicity
Alikhan, F. S., & Maibach, H. I. (2011) · Cutaneous and Ocular Toxicology · doi:10.3109/15569527.2011.560914 · Cited by 30
Aardema, M. J., Barnett, B., Mun, G. C., Dahl, E. L., Curren, R. D., Hewitt, N. J., & Pfuhler, S. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2012.08.009 · Cited by 29
Functionality and specificity of gene markers for skin sensitization in dendritic cells
Lambrechts, N., Nelissen, I., Tendeloo, V. F. V., Witters, H. E., Heuvel, R. V. D., Hooyberghs, J., & Schoeters, G. E. R. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.02.015 · Cited by 26
Hoffmann, P., Bentley, P., Sahota, P. S., Schoenfeld, H. A., Martin, L., Longo, L., Spaet, R. H., Moulin, P., Pantano, S., Dubost, V., et al. (2014) · Toxicologic Pathology · doi:10.1177/0192623313516828 · Cited by 26
Chen, X., He, Z., Zhou, Z., Yang, T., Zhang, X., Yang, Y., Duan, W., & Zhou, S. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12469 · Cited by 24
Evaluation of a human in vitro skin test for predicting drug hypersensitivity reactions
Ahmed, S. S., Whritenour, J., Ahmed, M. M., Bibby, L. A., Darby, L., Wang, X. N., Watson, J., & Dickinson, A. M. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.02.005 · Cited by 23
Self-citationCorti, D., Galbiati, V., Gatti, N., Marinovich, M., Galli, C. L., & Corsini, E. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.04.012 · Cited by 20
Roberts, D. W. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.07.014 · Cited by 20
Immunological principles of T-cell-mediated adverse drug reactions in skin
Naisbitt, D. J., Pirmohamed, M., & Park, B. K. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.109 · Cited by 19
Roy, S. K., Kulkarni, R. M., Hewitt, N. J., & Aardema, M. J. (2016) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2016.05.010 · Cited by 16
Kodji, X., Aubdool, A. A., & Brain, S. D. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.09.002 · Cited by 15
Research works printed but not linked: 17
- Abd, 2016, J. Clin. Pharmacol., 8, 163
- OECD , Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing , 2010
- G. F. Gerberick , J. A.Troutman , L. M.Foertsch and P. S.Kern , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 225–233
- A. Natsh , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 235–248
- E. Corsini and V.Galbiati , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 263–272
- T. Ramirez , A.Mehling and R.Landsiedel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 249–262
- D. Keller , C.Bauch and P.Patel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 377–391
- H. Sakaguchi and T.Ashikaga , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 289–309
- N. Alepee , C.Piroird and L.Nardelli , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 311–330
- M. Lindstedt , K. S.Zeller , H.Johansson and C.Borrebaeck , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 393–403
- N. Lambrechts , G.Schoeters , R.Van Den Heuvel , H.Witters , I.Nelissen and J.Hooyberghs , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 347–359
- P. R. Esser and S. F.Martin , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 449–454
- S. Pfuhler and K.Reisinger , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 513–525
- K. Reisinger and S.Pfuhler , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 527–539
- H. Kandarova and M.Liebsch , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 483–503
- H. Kojima , K.Hosoi and S.Onoue , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 477–482
- Coimbra, 2015, Ann. Transl. Med., 3, 76
Cited by
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“Members of the IQ Consortium recently published two manuscripts with recommendations for in vitro model development and assay qualification of lung and skin models to facilitate their wider adoption of use within the pharmaceutical industry (Ainslie et al., 2019; Hardwick et al. 2019).”
MethodKohl, Y., Rundén‐Pran, E., Mariussen, E., Hesler, M., Yamani, N. E., Longhin, E., & Dušinská, M. (2020) · Nanomaterials · doi:10.3390/nano10101911 · Cited by 123
Fabre, K., Berridge, B., Proctor, W. R., Ralston, S., Will, Y., Baran, S. W., Yoder, G., & Van Vleet, T. R. (2020) · Lab on a Chip · doi:10.1039/c9lc01168d · Cited by 116
Self-citation
Metadata
- Authors
- Hardwick, R. N., Betts, C. J., Whritenour, J., Sura, R., Thamsen, M., Kaufman, E. H., & Fabre, K.
- Affiliations
- Theravance Biopharma (United States) (US)
- AstraZeneca (United Kingdom) (GB)
- Pfizer (United States) (US)
- AbbVie (United States) (US)
- Corresponding author
- Hardwick, Rhiannon N.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 20
- Issue
- 2
- Pages
- 199-214
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2979806580
- Cited by
- 48
- References
- 73
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 4
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- drug-induced skin toxicity, microphysiological systems, organ-on-a-chip, skin organoids, skin irritation, skin corrosion, skin sensitization, percutaneous absorption, phototoxicity, genotoxicity, hair follicle, innervation, drug development
- MeSH terms
- Drug Development, Animals, Drug Industry, Pharmaceutical Preparations, Humans, Models, Biological, Skin, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.